null - FindTrial

NA - DFIL2-REP

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2020-005068-70-FR

Enrollment

Registered

2020-10-27

Start date

2021-01-07

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Product Name: Aldesleukine Product Code: ILT-101 Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: Aldesleukin CAS Number: 110942-02-4 Current Sponsor code: ILT101 Concentrat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? yes Number of subjects for this age range: 10 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range 14 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Main Objective: NA ;Secondary Objective: NA;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA	—

Secondary

Measure	Time frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA	—

Countries

France

Contacts

Public ContactDRCI Hôpital St Louis

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

karine.seymour@aphp.fr

Outcome results